Sector Focus

Healthcare stewards see success on access to vaccines

The pandemic has brought the issue of global access into the mainstream for both investors and companies. When AstraZeneca chief executive Pascal Soriot announced the pharmaceutical company’s decision to begin generating profit on its sales of Covid-19 vaccine in November 2021, some may have perceived this as a step backwards for ...

To continue reading

Already a subscriber? Log in
  • Unlimited access to all content.
  • Email alerts highlighting key industry insight.
  • Invitations to attend exclusive roundtables and events.
  • The Sustainable Views Policy Tracker - deep insight on ESG regulations and deadlines.
Request Free Trial

Read Next:

EU flag
Policy & Regulation

Risks emerge from patchwork European sustainability approaches

November 9, 2021
The opportunity for regulatory arbitrage in the EU may lead to further and tighter regulatory intervention The lack of minimum standards backing up asset managers’ sustainable disclosures has created a... Read more
Read more